1. Home
  2. INEO vs BCDA Comparison

INEO vs BCDA Comparison

Compare INEO & BCDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INEO
  • BCDA
  • Stock Information
  • Founded
  • INEO 2022
  • BCDA N/A
  • Country
  • INEO Singapore
  • BCDA United States
  • Employees
  • INEO 139
  • BCDA N/A
  • Industry
  • INEO
  • BCDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • INEO
  • BCDA Health Care
  • Exchange
  • INEO NYSE
  • BCDA Nasdaq
  • Market Cap
  • INEO 9.9M
  • BCDA 10.1M
  • IPO Year
  • INEO N/A
  • BCDA N/A
  • Fundamental
  • Price
  • INEO $0.93
  • BCDA $2.13
  • Analyst Decision
  • INEO
  • BCDA Strong Buy
  • Analyst Count
  • INEO 0
  • BCDA 1
  • Target Price
  • INEO N/A
  • BCDA $25.00
  • AVG Volume (30 Days)
  • INEO 84.6K
  • BCDA 83.8K
  • Earning Date
  • INEO 05-19-2025
  • BCDA 08-12-2025
  • Dividend Yield
  • INEO N/A
  • BCDA N/A
  • EPS Growth
  • INEO N/A
  • BCDA N/A
  • EPS
  • INEO 0.00
  • BCDA N/A
  • Revenue
  • INEO $58,333,000.00
  • BCDA $3,000.00
  • Revenue This Year
  • INEO N/A
  • BCDA N/A
  • Revenue Next Year
  • INEO N/A
  • BCDA N/A
  • P/E Ratio
  • INEO $2,031.43
  • BCDA N/A
  • Revenue Growth
  • INEO N/A
  • BCDA N/A
  • 52 Week Low
  • INEO $0.47
  • BCDA $1.63
  • 52 Week High
  • INEO $8.27
  • BCDA $4.66
  • Technical
  • Relative Strength Index (RSI)
  • INEO N/A
  • BCDA 43.00
  • Support Level
  • INEO N/A
  • BCDA $2.22
  • Resistance Level
  • INEO N/A
  • BCDA $2.42
  • Average True Range (ATR)
  • INEO 0.00
  • BCDA 0.12
  • MACD
  • INEO 0.00
  • BCDA -0.02
  • Stochastic Oscillator
  • INEO 0.00
  • BCDA 20.53

About INEO INNEOVA HOLDINGS LIMITED

INNEOVA Holdings Ltd is a Singapore-based provider of Original Equipment Manufacturer (OEM), third-party branded and in-house branded replacement parts for motor vehicles and non-vehicle combustion engines. The two segments include off- highway business segment and the other is On-Highway Business Segment.

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Share on Social Networks: